Your browser doesn't support javascript.
loading
Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors.
Iyer, Renuka V; Konda, Bhavana; Fountzilas, Christos; Mukherjee, Sarbajit; Owen, Dwight; Attwood, Kristopher; Wang, Chong; Maguire, Orla; Minderman, Hans; Suffren, Sheryl-Ann; Hicks, Karen; Wilton, John; Bies, Robert; Casucci, Danielle; Reidy-Lagunes, Diane; Shah, Manisha.
Afiliação
  • Iyer RV; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Konda B; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Fountzilas C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Mukherjee S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Owen D; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Attwood K; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Wang C; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Maguire O; Flow and Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Minderman H; Flow and Image Cytometry Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Suffren SA; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
  • Hicks K; Department of Clinical Research Services, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Wilton J; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Bies R; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Casucci D; Department of Clinical Research Services, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Reidy-Lagunes D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shah M; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Cancer ; 126(16): 3689-3697, 2020 08 15.
Article em En | MEDLINE | ID: mdl-32525561
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos / Indóis / Neovascularização Patológica Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tumores Neuroendócrinos / Indóis / Neovascularização Patológica Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article